Related Experiment Videos
Retroperitoneal malignant schwannoma. A case report
M Trifero1, F M Frattaroli, A M Ciccone
12nd Surgical Department, University La Sapienza Rome, Italy.
Tumori
|June 30, 1994
Summary
Isolated malignant schwannomas of the retroperitoneum are rare and aggressive. Radical surgery offers the best chance for diagnosis and symptom relief, despite a poor prognosis.
Area of Science:
- Oncology
- Surgical Pathology
Background:
- Malignant schwannomas are rare retroperitoneal neoplasms, accounting for 0.01% of such tumors.
- These tumors, when isolated and unassociated with Von Recklinghausen's disease, present a poor prognosis with a 5-year survival rate of 50% post-radical surgery.
- Differentiation from other retroperitoneal sarcomas is challenging without histological and immunohistochemical analysis.
Observation:
- A case report details a 62-year-old woman with a large (20 cm) retroperitoneal malignant schwannoma.
- The patient underwent successful radical surgical excision with no immediate postoperative complications.
- Despite surgical success, the patient developed diffuse metastases eight months post-surgery, succumbing to the disease.
Findings:
- Histological and immunohistochemical examinations are crucial for definitive diagnosis of retroperitoneal malignant schwannoma.
- Radical surgical excision is the primary treatment modality for isolated retroperitoneal malignant schwannoma.
- Complete surgical removal can provide significant and potentially prolonged symptomatic relief.
Implications:
- Radical surgery, while not curative in this case, remains the optimal therapeutic approach for isolated retroperitoneal malignant schwannoma.
- Early diagnosis and surgical intervention are critical for improving patient outcomes and survival rates.
- Further research into multimodal treatment strategies may be warranted to improve long-term survival for this rare malignancy.